Gilead Sciences, Inc.
GILD.SW News Today: Stay Updated with the Latest Gilead Sciences, Inc. News in Real Time
Find GILD.SW news now at Meyka AI. Stay informed with the latest Gilead Sciences, Inc. stocks updates, including price news, market analysis, and expert insights.
Craig-Hallum Maintains Buy on Citi Trends, Inc. (CTRN) March 18, 2026
CTRN analyst rating update: Craig-Hallum maintained Buy and raised PT to $67 on March 18, 2026
Craig‑Hallum Maintains Hold on Oklo Inc. (OKLO) March 2026
OKLO analyst rating: Craig‑Hallum maintained Hold and cut PT to $71 on March 18, 2026
6L9.F ViewRay, Inc. (XETRA) up 2400% pre-market 02 Apr 2026: watch volume for volatility
6L9.F stock jumps pre-market to **€0.025** on heavy volume; quick look at drivers, valuation, Meyka grade and forecast
BL BlackLine, Inc. Mar 18, 2026 BMO Maintains Market Perform, PT $44
BMO maintains Market Perform on BlackLine (BL) Mar 18, 2026. BL analyst rating cuts PT to $44. Meyka grade B+
ETI.CN stock: EnviroMetal Technologies (CNQ) rises to C$0.01 in market hours — what traders should watch
ETI.CN stock rises to C$0.01 in Canada market hours; low liquidity and thin float drive volatility
Craig-Hallum Maintains Buy on Xtant Medical (XTNT) March 18, 2026
XTNT analyst rating: Craig-Hallum maintained Buy on March 18, 2026 after lowering price target due to expected margin pressure
Craig-Hallum Maintains Buy on comScore (SCOR) March 2026
Craig-Hallum maintains Buy on comScore; SCOR analyst rating upheld after March 18, 2026 bounce-back quarter
RBC Maintains Outperform on Constellation Brands (STZ) March 18, 2026
RBC maintained Outperform on Constellation Brands (STZ) March 18, 2026. STZ analyst rating explained and investor implications
Jefferies Maintains Buy for CTMX (CytomX Therapeutics) March 18, 2026
Jefferies maintained Buy on CTMX March 18, 2026. Read CTMX analyst rating, $16 PT, and Meyka AI grade B+